{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:58:36Z","timestamp":1793642316882,"version":"4.5.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,7,25]],"date-time":"2013-07-25T00:00:00Z","timestamp":1374710400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-244x-13-196","type":"journal-article","created":{"date-parts":[[2013,7,25]],"date-time":"2013-07-25T17:26:33Z","timestamp":1374773193000},"source":"Crossref","is-referenced-by-count":120,"title":["A randomized double blind placebo controlled clinical trial of N-Acetylcysteine added to risperidone for treating autistic disorders"],"prefix":"10.1186","volume":"13","author":[{"given":"Ahmad","family":"Ghanizadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebrahim","family":"Moghimi-Sarani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,25]]},"reference":[{"issue":"9","key":"1383_CR1","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1007\/s10803-012-1444-9","volume":"42","author":"E Kocovska","year":"2012","unstructured":"Kocovska E, Biskupsto R, Carina Gillberg I, Ellefsen A, Kampmann H, Stora T, Billstedt E, Gillberg C: The Rising Prevalence of Autism: A Prospective Longitudinal Study in the Faroe Islands. J Autism Dev Disord. 2012, 42 (9): 1959-1966. 10.1007\/s10803-012-1444-9.","journal-title":"J Autism Dev Disord"},{"issue":"4","key":"1383_CR2","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s10803-007-0445-6","volume":"38","author":"A Ghanizadeh","year":"2008","unstructured":"Ghanizadeh A: A preliminary study on screening prevalence of pervasive developmental disorder in schoolchildren in Iran. J Autism Dev Disord. 2008, 38 (4): 759-763. 10.1007\/s10803-007-0445-6.","journal-title":"J Autism Dev Disord"},{"issue":"1","key":"1383_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/1362361311407091","volume":"16","author":"SA Samadi","year":"2012","unstructured":"Samadi SA, Mahmoodizadeh A, McConkey R: A national study of the prevalence of autism among five-year-old children in Iran. Autism. 2012, 16 (1): 5-14. 10.1177\/1362361311407091.","journal-title":"Autism"},{"issue":"3","key":"1383_CR4","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/aur.239","volume":"5","author":"M Elsabbagh","year":"2012","unstructured":"Elsabbagh M, Divan G, Koh YJ, Kim YS, Kauchali S, Marcin C, Montiel-Nava C, Patel V, Paula CS, Wang C, et al: Global prevalence of autism and other pervasive developmental disorders. Autism research: official journal of the International Society for Autism Research. 2012, 5 (3): 160-179. 10.1002\/aur.239.","journal-title":"Autism research: official journal of the International Society for Autism Research"},{"issue":"4","key":"1383_CR5","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/j.1750-3639.2007.00102.x","volume":"17","author":"CA Pardo","year":"2007","unstructured":"Pardo CA, Eberhart CG: The neurobiology of autism. Brain Pathol. 2007, 17 (4): 434-447. 10.1111\/j.1750-3639.2007.00102.x.","journal-title":"Brain Pathol"},{"issue":"12","key":"1383_CR6","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1038\/nn.2924","volume":"14","author":"MW State","year":"2011","unstructured":"State MW, Levitt P: The conundrums of understanding genetic risks for autism spectrum disorders. Nat Neurosci. 2011, 14 (12): 1499-1506. 10.1038\/nn.2924.","journal-title":"Nat Neurosci"},{"issue":"23","key":"1383_CR7","doi-asserted-by":"publisher","first-page":"4000","DOI":"10.2174\/092986712802002572","volume":"19","author":"A Ghanizadeh","year":"2012","unstructured":"Ghanizadeh A, Akhondzadeh S, Hormozi , Makarem A, Abotorabi M, Firoozabadi A: Glutathione-related Factors and Oxidative Stress in Autism, a Review. Curr Med Chem. 2012, 19 (23): 4000-4005. 10.2174\/092986712802002572.","journal-title":"Curr Med Chem"},{"issue":"4","key":"1383_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1179\/1351000211Y.0000000004","volume":"16","author":"S Leoncini","year":"2011","unstructured":"Leoncini S, De Felice C, Signorini C, Pecorelli A, Durand T, Valacchi G, Ciccoli L, Hayek J: Oxidative stress in Rett syndrome: natural history, genotype, and variants. Redox Rep. 2011, 16 (4): 145-153. 10.1179\/1351000211Y.0000000004.","journal-title":"Redox Rep"},{"issue":"3","key":"1383_CR9","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s10803-011-1260-7","volume":"42","author":"S Melnyk","year":"2012","unstructured":"Melnyk S, Fuchs GJ, Schulz E, Lopez M, Kahler SG, Fussell JJ, Bellando J, Pavliv O, Rose S, Seidel L, et al: Metabolic imbalance associated with methylation dysregulation and oxidative damage in children with autism. J Autism Dev Disord. 2012, 42 (3): 367-377. 10.1007\/s10803-011-1260-7.","journal-title":"J Autism Dev Disord"},{"issue":"1\u20132","key":"1383_CR10","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jneuroim.2010.10.005","volume":"232","author":"A Ghanizadeh","year":"2011","unstructured":"Ghanizadeh A: Oxidative stress may mediate association of stereotypy and immunity in autism, a novel explanation with clinical and research implications. J Neuroimmunol. 2011, 232 (1\u20132): 194-195.","journal-title":"J Neuroimmunol"},{"issue":"3","key":"1383_CR11","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jpsychires.2011.10.004","volume":"46","author":"M Parellada","year":"2012","unstructured":"Parellada M, Moreno C, Mac-Dowell K, Leza JC, Giraldez M, Bailon C, Castro C, Miranda-Azpiazu P, Fraguas D, Arango C: Plasma antioxidant capacity is reduced in Asperger syndrome. J Psychiatr Res. 2012, 46 (3): 394-401. 10.1016\/j.jpsychires.2011.10.004.","journal-title":"J Psychiatr Res"},{"issue":"1\u20133","key":"1383_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12011-011-9280-x","volume":"147","author":"MM Essa","year":"2012","unstructured":"Essa MM, Guillemin GJ, Waly MI, Al-Sharbati MM, Al-Farsi YM, Hakkim FL, Ali A, Al-Shafaee MS: Increased markers of oxidative stress in autistic children of the sultanate of oman. Biol Trace Elem Res. 2012, 147 (1\u20133): 25-27.","journal-title":"Biol Trace Elem Res"},{"issue":"5","key":"1383_CR13","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.plefa.2005.06.002","volume":"73","author":"X Ming","year":"2005","unstructured":"Ming X, Stein TP, Brimacombe M, Johnson WG, Lambert GH, Wagner GC: Increased excretion of a lipid peroxidation biomarker in autism. Prostaglandins Leukot Essent Fatty Acids. 2005, 73 (5): 379-384. 10.1016\/j.plefa.2005.06.002.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"5","key":"1383_CR14","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1179\/1351000211Y.0000000012","volume":"16","author":"LP Damodaran","year":"2011","unstructured":"Damodaran LP, Arumugam G: Urinary oxidative stress markers in children with autism. Redox Rep. 2011, 16 (5): 216-222. 10.1179\/1351000211Y.0000000012.","journal-title":"Redox Rep"},{"issue":"1","key":"1383_CR15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s12011-010-8840-9","volume":"143","author":"NA Meguid","year":"2011","unstructured":"Meguid NA, Dardir AA, Abdel-Raouf ER, Hashish A: Evaluation of oxidative stress in autism: defective antioxidant enzymes and increased lipid peroxidation. Biol Trace Elem Res. 2011, 143 (1): 58-65. 10.1007\/s12011-010-8840-9.","journal-title":"Biol Trace Elem Res"},{"key":"1383_CR16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000332202","volume":"2","author":"A Ghanizadeh","year":"2011","unstructured":"Ghanizadeh A: Targeting Mitochondria by Olesoxime or Complement 1q Binding Protein as a Novel Management for Autism: A Hypothesis. Molecular Syndromology. 2011, 2: 50-52.","journal-title":"Molecular Syndromology"},{"key":"1383_CR17","volume-title":"Mitochondrion","author":"A Ghanizadeh","year":"2012","unstructured":"Ghanizadeh A, Berk M, Farrashbandi H, Alavi Shoushtari A, Villagonzalo KA: Targeting the mitochondrial electron transport chain in autism, a systematic review and synthesis of a novel therapeutic approach. Mitochondrion. 2012, 2012: 10.1016\/j.mito.2012.10.001."},{"key":"1383_CR18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.brainres.2011.06.063","volume":"1410","author":"D Banji","year":"2011","unstructured":"Banji D, Banji OJ, Abbagoni S, Hayath MS, Kambam S, Chiluka VL: Amelioration of behavioral aberrations and oxidative markers by green tea extract in valproate induced autism in animals. Brain Res. 2011, 1410: 141-151.","journal-title":"Brain Res"},{"issue":"10","key":"1383_CR19","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/j.freeradbiomed.2012.03.011","volume":"52","author":"A Frustaci","year":"2012","unstructured":"Frustaci A, Neri M, Cesario A, Adams JB, Domenici E, Dalla Bernardina B, Bonassi S: Oxidative stress-related biomarkers in autism: Systematic review and meta-analyses. Free Radic Biol Med. 2012, 52 (10): 2128-2141. 10.1016\/j.freeradbiomed.2012.03.011.","journal-title":"Free Radic Biol Med"},{"issue":"8","key":"1383_CR20","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1007\/s11064-012-0775-4","volume":"37","author":"A Chauhan","year":"2012","unstructured":"Chauhan A, Audhya T, Chauhan V: Brain Region-Specific Glutathione Redox Imbalance in Autism. Neurochem Res. 2012, 37 (8): 1681-1689. 10.1007\/s11064-012-0775-4.","journal-title":"Neurochem Res"},{"key":"1383_CR21","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/1471-2377-11-139","volume":"11","author":"YA Al-Yafee","year":"2011","unstructured":"Al-Yafee YA, Al-Ayadhi LY, Haq SH, El-Ansary AK: Novel metabolic biomarkers related to sulfur-dependent detoxification pathways in autistic patients of Saudi Arabia. BMC Neurol. 2011, 11: 139-10.1186\/1471-2377-11-139.","journal-title":"BMC Neurol"},{"issue":"2","key":"1383_CR22","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s11689-011-9077-4","volume":"3","author":"K Bowers","year":"2011","unstructured":"Bowers K, Li Q, Bressler J, Avramopoulos D, Newschaffer C, Fallin MD: Glutathione pathway gene variation and risk of autism spectrum disorders. J Neurodev Disord. 2011, 3 (2): 132-143. 10.1007\/s11689-011-9077-4.","journal-title":"J Neurodev Disord"},{"issue":"47","key":"1383_CR23","doi-asserted-by":"publisher","first-page":"35785","DOI":"10.1074\/jbc.M602799200","volume":"281","author":"V Vitvitsky","year":"2006","unstructured":"Vitvitsky V, Thomas M, Ghorpade A, Gendelman HE, Banerjee R: A functional transsulfuration pathway in the brain links to glutathione homeostasis. J Biol Chem. 2006, 281 (47): 35785-35793. 10.1074\/jbc.M602799200.","journal-title":"J Biol Chem"},{"issue":"12","key":"1383_CR24","doi-asserted-by":"publisher","first-page":"682","DOI":"10.12659\/MSM.882125","volume":"17","author":"J Kern","year":"2011","unstructured":"Kern J, Geier D, Adams J, Garver C, Audhya T, Geier M: A clinical trial of glutathione supplementation in autism spectrum disorders. Med Sci Monit. 2011, 17 (12): 682-","journal-title":"Med Sci Monit"},{"issue":"7","key":"1383_CR25","doi-asserted-by":"publisher","first-page":"737","DOI":"10.3109\/02656736.2011.604665","volume":"27","author":"A Ghanizadeh","year":"2011","unstructured":"Ghanizadeh A: Could fever and neuroinflammation play a role in the neurobiology of autism? A subject worthy of more research. Int J Hyperthermia. 2011, 27 (7): 737-738. 10.3109\/02656736.2011.604665.","journal-title":"Int J Hyperthermia"},{"issue":"6","key":"1383_CR26","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/nrd3761","volume":"11","author":"C Harrison","year":"2012","unstructured":"Harrison C: Neurodevelopmental disorders: Glutamate blockers show benefit in models of autism spectrum disorders. Nat Rev Drug Discov. 2012, 11 (6): 440-441.","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"1383_CR27","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/01.jcp.0000270082.30500.69","volume":"27","author":"H Niederhofer","year":"2007","unstructured":"Niederhofer H: Glutamate antagonists seem to be slightly effective in psychopharmacologic treatment of autism. J Clin Psychopharmacol. 2007, 27 (3): 317-318. 10.1097\/01.jcp.0000270082.30500.69.","journal-title":"J Clin Psychopharmacol"},{"issue":"11","key":"1383_CR28","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1007\/s10803-010-1174-9","volume":"41","author":"A Ghanizadeh","year":"2011","unstructured":"Ghanizadeh A: c-Kit+ cells transplantation as a new treatment for autism, a novel hypothesis with important research and clinical implication. J Autism Dev Disord. 2011, 41 (11): 1591-1592. 10.1007\/s10803-010-1174-9.","journal-title":"J Autism Dev Disord"},{"issue":"8","key":"1383_CR29","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.arcmed.2010.10.012","volume":"41","author":"A Ghanizadeh","year":"2010","unstructured":"Ghanizadeh A: Methionine sulfoximine may improve inflammation in autism, a novel hypothesized treatment for autism. Arch Med Res. 2010, 41 (8): 651-652. 10.1016\/j.arcmed.2010.10.012.","journal-title":"Arch Med Res"},{"issue":"5","key":"1383_CR30","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1007\/s11064-010-0381-2","volume":"36","author":"A Ghanizadeh","year":"2011","unstructured":"Ghanizadeh A: Targeting of glycine site on NMDA receptor as a possible new strategy for autism treatment. Neurochem Res. 2011, 36 (5): 922-923. 10.1007\/s11064-010-0381-2.","journal-title":"Neurochem Res"},{"issue":"2","key":"1383_CR31","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1503\/jpn.100057","volume":"36","author":"O Dean","year":"2011","unstructured":"Dean O, Giorlando F, Berk M: N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action. J Psychiatry Neurosci. 2011, 36 (2): 78-86.","journal-title":"J Psychiatry Neurosci"},{"issue":"6","key":"1383_CR32","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/0891-5849(89)90066-X","volume":"6","author":"OI Aruoma","year":"1989","unstructured":"Aruoma OI, Halliwell B, Hoey BM, Butler J: The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med. 1989, 6 (6): 593-597. 10.1016\/0891-5849(89)90066-X.","journal-title":"Free Radic Biol Med"},{"issue":"9","key":"1383_CR33","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1038\/npp.2012.66","volume":"37","author":"L Schmaal","year":"2012","unstructured":"Schmaal L, Veltman DJ, Nederveen A, van den Brink W, Goudriaan AE: N-Acetylcysteine Normalizes Glutamate Levels in Cocaine-Dependent Patients: A Randomized Crossover Magnetic Resonance Spectroscopy Study. Neuropsychopharmacology. 2012, 37 (9): 2143-2152. 10.1038\/npp.2012.66.","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"1383_CR34","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.biopsych.2008.03.004","volume":"64","author":"M Berk","year":"2008","unstructured":"Berk M, Copolov D, Dean O, Lu K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Judd F, Katz F, Katz P: N-acetyl cysteine as a glutathione precursor for schizophrenia\u00e2\u20ac\u201da double-blind, randomized, placebo-controlled trial. Biol Psychiatry. 2008, 64 (5): 361-368. 10.1016\/j.biopsych.2008.03.004.","journal-title":"Biol Psychiatry"},{"issue":"1-3","key":"1383_CR35","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.jad.2011.06.005","volume":"135","author":"M Berk","year":"2011","unstructured":"Berk M, Dean O, Cotton SM, Gama CS, Kapczinski F, Fernandes BS, Kohlmann K, Jeavons S, Hewitt K: The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: An open label trial. J Affect Disord. 2011, 135 (1-3): 389-394. 10.1016\/j.jad.2011.06.005.","journal-title":"J Affect Disord"},{"issue":"6","key":"1383_CR36","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1177\/1533317508325093","volume":"23","author":"A Chan","year":"2009","unstructured":"Chan A, Paskavitz J, Remington R, Rasmussen S, Shea TB: Efficacy of a vitamin\/nutriceutical formulation for early-stage Alzheimer\u2019s disease: a 1-year, open-label pilot study with an 16-month caregiver extension. Am J Alzheimers Dis Other Demen. 2009, 23 (6): 571-585.","journal-title":"Am J Alzheimers Dis Other Demen"},{"issue":"3","key":"1383_CR37","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2174\/1871523011312030003","volume":"12","author":"A Ghanizadeh","year":"2013","unstructured":"Ghanizadeh A, Derakhshan N, Berk M: N-acetylcysteine Versus Placebo for Treating Nail Biting, A Double Blind Randomized Placebo Controlled Clinical Trial. Anti-inflammatory & anti-allergy agents in medicinal chemistry. 2013, 12 (3): 223-228. 10.2174\/1871523011312030003.","journal-title":"Anti-inflammatory & anti-allergy agents in medicinal chemistry"},{"issue":"1","key":"1383_CR38","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/lt.21246","volume":"14","author":"C Kortsalioudaki","year":"2008","unstructured":"Kortsalioudaki C, Taylor RM, Cheeseman P, Bansal S, Mieli\u00e2\u20ac Vergani G, Dhawan A: Safety and efficacy of N\u00e2\u20ac acetylcysteine in children with non\u00e2\u20ac acetaminophen\u00e2\u20ac induced acute liver failure. Liver Transpl. 2008, 14 (1): 25-30. 10.1002\/lt.21246.","journal-title":"Liver Transpl"},{"issue":"5","key":"1383_CR39","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1056\/NEJMoa013171","volume":"347","author":"JT McCracken","year":"2002","unstructured":"McCracken JT, McGough J, Shah B, Cronin P, Hong D, Aman MG, Arnold LE, Lindsay R, Nash P, Hollway J, et al: Risperidone in children with autism and serious behavioral problems. N Engl J Med. 2002, 347 (5): 314-321. 10.1056\/NEJMoa013171.","journal-title":"N Engl J Med"},{"issue":"6","key":"1383_CR40","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1542\/peds.2008-3782","volume":"124","author":"R Owen","year":"2009","unstructured":"Owen R, Sikich L, Marcus RN, Corey-Lisle P, Manos G, McQuade RD, Carson WH, Findling RL: Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics. 2009, 124 (6): 1533-1540. 10.1542\/peds.2008-3782.","journal-title":"Pediatrics"},{"issue":"5","key":"1383_CR41","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/BF02172145","volume":"24","author":"C Lord","year":"1994","unstructured":"Lord C, Rutter M, Le Couteur A: Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord. 1994, 24 (5): 659-685. 10.1007\/BF02172145.","journal-title":"J Autism Dev Disord"},{"issue":"1","key":"1383_CR42","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.pnpbp.2009.09.012","volume":"34","author":"S Akhondzadeh","year":"2010","unstructured":"Akhondzadeh S, Fallah J, Mohammadi MR, Imani R, Mohammadi M, Salehi B, Ghanizadeh A, Raznahan M, Mohebbi-Rasa S, Rezazadeh SA, et al: Double-blind placebo-controlled trial of pentoxifylline added to risperidone: effects on aberrant behavior in children with autism. Prog Neuropsychopharmacol Biol Psychiatry. 2010, 34 (1): 32-36. 10.1016\/j.pnpbp.2009.09.012.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1383_CR43","volume-title":"Child Psychiatry Hum Dev","author":"A Ghanizadeh","year":"2013","unstructured":"Ghanizadeh A, Sahraeizadeh A, Berk M: A Head-to-Head Comparison of Aripiprazole and Risperidone for Safety and Treating Autistic Disorders, a Randomized Double Blind Clinical Trial. Child Psychiatry Hum Dev. 2013, [Epub ahead of print]"},{"issue":"5","key":"1383_CR44","first-page":"485","volume":"89","author":"MG Aman","year":"1985","unstructured":"Aman MG, Singh NN, Stewart AW, Field CJ: The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects. Am J Ment Defic. 1985, 89 (5): 485-491.","journal-title":"Am J Ment Defic"},{"issue":"15","key":"1383_CR45","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1002\/sim.1519","volume":"22","author":"J Shao","year":"2003","unstructured":"Shao J, Zhong B: Last observation carry-forward and last observation analysis. Stat Med. 2003, 22 (15): 2429-2441. 10.1002\/sim.1519.","journal-title":"Stat Med"},{"issue":"10","key":"1383_CR46","first-page":"985","volume":"17","author":"A Ghanizadeh","year":"2012","unstructured":"Ghanizadeh A, Derakhshan N: N-acetylcysteine for treatment of autism, a case report. J Res Med Sci. 2012, 17 (10): 985-987.","journal-title":"J Res Med Sci"},{"issue":"11","key":"1383_CR47","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.biopsych.2012.01.014","volume":"71","author":"AY Hardan","year":"2012","unstructured":"Hardan AY, Fung LK, Libove RA, Obukhanych TV, Nair S, Herzenberg LA, Frazier TW, Tirouvanziam R: A randomized controlled pilot trial of oral N-acetylcysteine in children with autism. Biol Psychiatry. 2012, 71 (11): 956-961. 10.1016\/j.biopsych.2012.01.014.","journal-title":"Biol Psychiatry"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-13-196.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-244X-13-196\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-13-196","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T12:26:43Z","timestamp":1688387203000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/1471-244X-13-196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,25]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1383"],"URL":"https:\/\/doi.org\/10.1186\/1471-244x-13-196","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,25]]},"article-number":"196"}}